Explorer
Japan: Remdesivir approved for Coronavirus treatment
The development of Remdesivir had started in 2009 and was used for Ebola patients during the 2000s. The medication was recently given a fast-track approval in Japan for the treatment of Coronavirus patients. Gilead Sciences company that produces Remdesivir, had applied for the approval of this drug only three days ago.
The US is also planning to begin treating seriously ill COVID-19 patients with Remdesivir.
The US is also planning to begin treating seriously ill COVID-19 patients with Remdesivir.
India
PARLIAMENT DEADLOCK: Opposition Stands Firm on Education Minister’s Resignation Before Discussion
Politics: Opposition Targets PM Modi Over Silence on Student Protest
Maharashtra Politics: Uddhav-Raj Thackeray Target Government Over Student Protests, Announce Mega March
BJP vs Opposition: NEET Row Escalates in Parliament as Opposition Demands Education Minister’s Resignation
Parliament NEET Row: BJP Accuses Congress of Avoiding NEET Debate, Highlights Fast-Track Court Decision
View More
Top Headlines
News
Education Secretary Vineet Joshi Replaced; Delhi HC Sets Up Fast-Track Court
India
No Cap With Megha Prasad | An Examination Can Be Held Again. A Student's Lost Year Cannot
News
Youth Anger Over NEET Leaks Signals The End Of Youth-Ignoring Politics
News
OPINION | Cockroach’s Mosaic Vision On India’s Global Image
Trending News
